Tumour‐sphere assay indicated that DAB2IP‐inhibition enhanced and DAB2IP‐overexpression attenuated self‐renewal ability in TNBC cells (Figure 2D and Figure S2E). The gene discussed is DAB2IP; the disease is neoplasm.